CORRELATION OF INTERSTITIAL PNEUMONIA WITH HUMAN CYTOMEGALOVIRUS-INDUCED LUNG INFECTION AND GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION
Ca. Muller et al., CORRELATION OF INTERSTITIAL PNEUMONIA WITH HUMAN CYTOMEGALOVIRUS-INDUCED LUNG INFECTION AND GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION, Medical microbiology and immunology, 184(3), 1995, pp. 115-121
In a retrospective analysis lung biopsy specimens obtained postmortem
from 30 consecutive allogeneic bone marrow transplant recipients who h
ad died of either interstitial pneumonitis (IP; 18/30 patients) or var
ious other causes (12/30 patients) were studied for the local presence
of human cytomegalovirus (HCMV) by culture, in situ hybridization, po
lymerase chain reaction (PCR) and immunohistochemistry for HCMV protei
ns. All patients suffering from IP were found to be HCMV positive in t
he lung biopsy. PCR revealed the highest sensitivity for HCMV detectio
n in lung biopsies, but in 15/18 PCR-positive samples local HCMV infec
tion could be confirmed by at least one additional technique. All the
lung biopsies obtained from the 12 patients without IP were negative f
or HCMV by all techniques applied, except one with a weak HCMV-DNA sig
nal in the PCR assay. The severity of the clinical, as well as histolo
gical and immunohistological alterations in the lung did not correlate
with the amount of HCMV-DNA or the number of HCMV-positive cells dete
cted in the biopsy. An increase of HLA-class II antigen and of ICAM-1
expression on the alveolar epithelium, as well as presence of activate
d CD8(+) or CD4(+) lymphocytes infiltrating only HCMV-positive lung bi
opsies revealed T cell-mediated immune reactions to be involved in the
pathogenesis of IP. Since all analyzed patients presented with severe
acute or extensive chronic graft-versus-host disease (GVHD), but only
those with pulmonary HCMV infection developed IP, dissemination of HC
MV appears to be the primary requirement for the initiation of IP. GvH
D, however, may interfere with normal control of subsequent antiviral
immune responses and, thus, provoke the immunopathology of IP.